Pharm 21: Lasik make pee Flashcards
ADH MOA
Constricts vasculature and promotes water reabsorption via G-protein receptors
V1: vascular smooth muscle contriction
V2: collecting duct of principal cells
ADH V2 activity (MOA)
Gs g-protein
CAMP increases ->protein kinase A (PKA) increases
PKA increases aquaporin 2 activity
Aliskiren MOA and use
Renin inhibitor. Binds to active site inhibiting the binding of renin
Used for hypertension with renal insufficiency
Can be used w/ thiazides
Kinin levels w/ ACE inhibitors
Are increased
ACE inhibitors metabolism patterns
1) Captopril. Active, biotransformed to active metabolite
2) Enalapril/ Ramipril: prodrug. if at suffix then active
3) Lisinopril: active form, excreted unchanged by kidney
ACE inhibitor cough angioedema because
Potentiation of bradykinin
ACE inhibitors and potassium
Reduced aldosterone synthesis causes hyperK
Losartan and Valsartan MOA
AT1 receptor antagonist. —> Angotensin II inhibition
AT1 receptor antagonist vs ACE inhibittor
AT1 more complete angiotensin II inhibition, but no vasodilation
Nesiritide MOA and use
Recombinant BNP
Short term decompensated HF
Demclocycline MOA and use
MOA unk
Use for SIADH
tretracycline *
Conivaptan/tolvaptan MOA and use
V1/V2 (vasopressin) receptor antagonists
Tolvaptan is oral
use in SIADH and nephrogenic diabetes insipidus
Acetalozimide MOA
inhibit sodium reabsorption by noncompetitively and reversibly inhibiting carbonic anhydrase in proximal tubule cells
Acetazolimide compensation
NaCl and NaHCO3 reabsorption increases after some days
Acetozolamide uses
Mountain sickness, times when urine alkanization is needed
Mannitol MOA and use
Osmotic diuretic
Increased ICP
Loop diuretic consequences (acid/base)
Volume contraction alkalosis
Loop diuretics
Furosemide
Bumentanide
Torsemide
Ethacrynic acid (non sulfa)
Loop diuretics MOA
These agents reversibly and competitively inhibit the Na+-K+-2Cl− co-transporter NKCC2 in the apical (luminal) membrane of thick ascending loop epithelial cells
Lasix lab values
Hypocalcemia
Hypomagnesia
Hypokalemia
Thiazides MOA and use
competitive antagonists of the NCC Na+-Cl− co-transporter in the luminal membrane of distal convoluted tubule cells
Decrease urinary calcium
First line for hypertension (decreased mortality)
used for osteoporosis or stone prevention
Chlorthalidone
Used for night BP elevations
Central diabetes insipidus treatment
Desmopressin (replace ADH)
Spironolactone and eplerenone MOA
inhibit aldosterone action by binding to and preventing nuclear translocation of the mineralocorticoid receptor
Amiloride and trimterene MOA and use
competitive inhibitors of the ENaC Na+ channel in the apical membrane of collecting duct principal cells
Hypertension (Liddle’s)
Potassium sparing diuretics AEs
HyperK
Metabolic acidosis
Amiloride consideration with lithium
Helps with kidney issues
Liver failure ascites diuretic?
Potassium sparing